腫瘤壞死因子受體超家族成員1A(TNFR1)重組蛋白
Recombinant Tumor Necrosis Factor Receptor 1 (TNFR1)
CD120A; P55; TNFRSF1A; TBP1; FPF; TNF-R; TNF-R-I; TNF-R55; TNFAR; TNFR55; TNFR60; P55-R; P60; Tumor necrosis factor receptor 1; Tumor necrosis factor-binding protein 1
- 編號RPB499Hu02
- 物種Homo sapiens (Human,人) 相同的名稱,不同的物種。
- 來源原核表達
- 宿主E.coli
- 內(nèi)毒素水平<1.0EU/µg(LAL法測定)
- 亞細胞定位分泌
- 預(yù)測分子量23.7kDa
- 實際分子量27kDa(差異分析請參閱說明書)
- 片段與標簽Cys248~Met428 with N-terminal His Tag
- 緩沖液成份100mM NaHCO3, 500mM NaCl緩沖液(pH8.3,含有1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose和Proclin300)
- 性狀凍干粉
- 純度> 90%
- 等電點7.1
-
應(yīng)用
Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白,請參見活性蛋白。 - 下載 英文說明書 中文說明書
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價格 ¥ 1056 ¥ 2640 ¥ 5280 ¥ 15840 ¥ 39600
- 欲了解實際交易價格和更多情況,請與當?shù)亟?jīng)銷商聯(lián)系!
序列
用法
Reconstitute in ddH2O to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲存
避免反復(fù)凍融。2-8°C不超過一個月,-80°C不超過12個月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定,具體方法如下:在37°C孵育48小時,沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當?shù)臈l件下存儲,損失率低于5%。
增值服務(wù)
相關(guān)產(chǎn)品
編號 | 適用物種:Homo sapiens (Human,人) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) |
APB499Hu02 | 腫瘤壞死因子受體超家族成員1A(TNFR1)活性蛋白 | Cell?culture;?Activity?Assays. |
RPB499Hu03 | 腫瘤壞死因子受體超家族成員1A(TNFR1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPB499Hu01 | 腫瘤壞死因子受體超家族成員1A(TNFR1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
APB499Hu01 | 腫瘤壞死因子受體超家族成員1A(TNFR1)活性蛋白 | Cell?culture;?Activity?Assays. |
RPB499Hu02 | 腫瘤壞死因子受體超家族成員1A(TNFR1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
PAB499Hu01 | 腫瘤壞死因子受體超家族成員1A(TNFR1)多克隆抗體 | WB; IHC; ICC; IP. |
PAB499Hu02 | 腫瘤壞死因子受體超家族成員1A(TNFR1)多克隆抗體 | WB,IHC |
MAB499Hu21 | 腫瘤壞死因子受體超家族成員1A(TNFR1)單克隆抗體 | WB; IHC; ICC; IP. |
MEB499Hu | 腫瘤壞死因子受體超家族成員1A(TNFR1)檢測試劑盒(酶聯(lián)免疫吸附試驗法,小樣本) | Enzyme-linked immunosorbent assay for Antigen Detection. |
SEB499Hu | 腫瘤壞死因子受體超家族成員1A(TNFR1)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMB499Hu | 腫瘤壞死因子受體超家族成員1A(TNFR1)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻
雜志 | 參考文獻 |
PLoS ONE | A Combinatorial Relative Mass Value Evaluation of Endogenous Bioactive Proteins in Three-Dimensional Cultured Nucleus Pulposus Cells of Herniated Intervertebral Discs: Identification of Potential Target Proteins for Gene Therapeutic Approaches [Plosone: Source] |
Mediators of Inflammation | High Glucose Level Disturbs the Resveratrol-Evoked Curtailment of CX3CL1/CX3CR1 Signaling in Human Placental Circulation [pubmed:28655972] |
Annals of Neurology? | High complement levels in astrocyte‐derived exosomes of Alzheimer disease [Pubmed:29406582] |
International Journal of Immunopathology and Pharmacology | VEGF-R2 and TNF-R1 expression and cytokine production by samples of mammary adenocarcinomas and correlations with histopathological parameters of these?… [Pubmed:29985074] |
Cell Death & Disease | Inhibition of transmembrane TNF-α shedding by a specific antibody protects against septic shock [Pubmed: 31383857] |
Journal of Cardiovascular Translational Research | XPO1 Gene Therapy Attenuates Cardiac Dysfunction in Rats with Chronic Induced Myocardial Infarction [Pubmed: 31768947] |
Frontiers in Pharmacology | M10, a Myricetin-3-ObD-Lactose Sodium Salt, Prevents Ulcerative Colitis Through Inhibiting Necroptosis in Mice [Pubmed: 33041798] |
留言咨詢